Learn more

MEDLEY S A IND FARMACEUTICA

Overview
  • Total Patents
    13
About

MEDLEY S A IND FARMACEUTICA has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Brazil, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and medical technology are PAETZ JANA, ANDROSOLUTIONS INC and COMBINO PHARM SL.

Patent filings in countries

World map showing MEDLEY S A IND FARMACEUTICAs patent filings in countries

Patent filings per year

Chart showing MEDLEY S A IND FARMACEUTICAs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Negrao Alexandre Funari 6
#2 Funari Negrao Alexandre 2
#3 Alexandre Funari Negrao 1
#4 Faria Geraldo Eduardo De 1
#5 Negrão Alexandre Funari 1
#6 De Faria Geraldo Eduardo 1

Latest patents

Publication Filing date Title
EP2089022A2 Composition containing a mixture of antidepressants for treating premature ejaculation
BRPI0703656A pharmaceutical composition and method for treating sexual dysfunction, a device containing the same and its use
WO2008037044A1 Oxcarbazepine-containing oral formulation and a process to obtain the same
BRPI0605967A controlled release pharmaceutical composition, controlled release pharmaceutical form and process for obtaining a pharmaceutical form
WO2004108056A2 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease
BRPI0401556A Medicine set, drug association and medicine
WO2004089274A1 Drug packaging, or kit, or presentation facilitating self administration of drugs by patients
BR0303794A Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation
BR0302271A Medicines or medication set or medication kit, drug combination and medication
BR0202609A Method for treating patients who are sensitive, responsive to drugs, or who have problems that hinder the effectiveness of conventional treatments through the joint and differentiated administration of drugs.